The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 6
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Items 501–600 of 998
Turvey, S. J., McPhillie, M. J., Kearney, M. T., Muench, S. P., Simmons, K. J., & Fishwick, C. W. G. (2022) · RSC Medicinal Chemistry · doi:10.1039/d1md00300c · Cited by 25
“20 The insulin receptor (IR) acts as a conduit for insulin-encoded information, which is transferred via a complex intracellular signalling network including the critical signalling nodes phosphatidylinositol 3-kinase (PI3-K) and the serine/threonine kinase Akt, to regulate cell metabolism.”
McCullough, D., Harrison, T., Boddy, L. M., Enright, K. J., Amirabdollahian, F., Schmidt, M., Doenges, K., Quinn, K. D., Reisdorph, N. A., Mazidi, M., et al. (2022) · Nutrients · doi:10.3390/nu14183691 · Cited by 24
“Poor lifestyle habits and elevated VAT increase circulating free fatty acids, inflammatory cytokines and reactive oxygen species—biochemical mechanisms that contribute to IR [1,40].”
BackgroundThe Role of Individually Selected Diets in Obese Women with PCOS—A Review
Chudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Brudecki, G. P., & Zwoździak, B. (2022) · Nutrients · doi:10.3390/nu14214555 · Cited by 28
“In obese women with PCOS, especially as a result of the development of insulin resistance (IR), there is an increase in the concentration of free fatty acids and triglycerides in the serum, which leads to an increase in de novo hepatic lipogenesis and hyperlipidemia [98], and increased fat storage in skeletal muscle,…”
BackgroundFujiwara, S., Izawa, T., Mori, M., Atarashi, M., Yamate, J., & Kuwamura, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-25838-3 · Cited by 25
Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
Tian, Y., Zhang, J., Li, M., Jie, S., Bai, X., Zhang, H., Wang, Y., Chen, H., & Song, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1077590 · Cited by 25
Lee, J., Han, J. S., Kong, J., Ji, Y., Lyu, X., Lee, J., Li, P., & Kim, J. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.740464 · Cited by 26
“In mammals, ectopic lipid accumulation in liver or muscle is closely associated with insulin resistance and metabolic diseases (53).”
BackgroundBody composition and metabolic changes during a 520-day mission simulation to Mars
Strollo, F., Macchi, C., Eberini, I., Masini, M. A., Botta, M., Vassilieva, G. Y., Ничипорук, И. А., Monici, M., Santucci, D., Celotti, F., et al. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0861-9 · Cited by 22
Yang, S., Zhang, Y., Shen, F., Ma, X., Zhang, M., Hou, Y., & Bai, G. (2018) · FEBS Letters · doi:10.1002/1873-3468.13305 · Cited by 22
The eye as a novel imaging site in diabetes research
Yang, S.-N., & Berggren, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.005 · Cited by 24
Abulizi, A., Camporez, J. P., Jurczak, M. J., Høyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., & Vatner, D. F. (2019) · The FASEB Journal · doi:10.1096/fj.201802706r · Cited by 23
“activating PKCe, which impairs insulin signaling by decreasing insulin receptor tyrosine kinase activity (25).”
BackgroundSelf-citationYang, L., Qiu, T., Yao, X., Jiang, L., Wei, S., Pei, P., Wang, Z., Bai, J., Liu, X., Yang, G., et al. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.05.001 · Cited by 23
Song, Z., Yang, H., Zhou, L., & Yang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205132 · Cited by 26
“mechanisms of T2D pathogenesis are still missing to date, the proposed models are as follows [6,7].”
BackgroundWang, Z., Zuo, Z., Li, L., Ren, S., Gao, T., Fu, J., Hou, Y., Chen, Y., & Pi, J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01227-0 · Cited by 22
Sun, Y.-N., Huang, J.-Q., Chen, Z.-Z., Du, M., Ren, F.-Z., Luo, J., & Fang, B. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz236 · Cited by 22
Genome‐wide association studies: utility and limitations for research in physiology
Ciochetti, N. P., Lugli‐Moraes, B., da Silva, B. S., & Rovaris, D. L. (2023) · The Journal of Physiology · doi:10.1113/jp284241 · Cited by 32
“Additionally, it is known that lipid metabolism and adiposity are linked to insulin resistance and type 2 diabetes (Samuel & Shulman, 2016).”
Nutritional Mechanisms of Cancer Cachexia
Compton, S. L. E., Heymsfield, S. B., & Brown, J. C. (2024) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062122-015646 · Cited by 26
Potential Mechanisms for How Long-Term Physical Activity May Reduce Insulin Resistance
Lee-Ødegård, S., Olsén, T., Norheim, F., Drevon, C. A., & Birkeland, K. I. (2022) · Metabolites · doi:10.3390/metabo12030208 · Cited by 22
“Studies have revealed that expanding adipose tissue may lead to hypoxia and macrophage and immune cell infiltration that may enhance lipolysis and adipose tissue IR [13,14].”
BackgroundXu, S., 武汉大学基础医学院遗传学系, 湖. 武. 4., Li, Y., Wang, H.-P., Chen, W., Wang, Y., Song, Z., Liu, H., Zhong, S., Sun, Y., et al. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.167 · Cited by 24
Wang, X., Chen, Y., Huang, Z., Cai, Z., Yu, X., Chen, Z., Li, L., Chen, G., Wu, K., Zheng, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1054741 · Cited by 21
Meng, J., Wang, Y., Lv, Z., Qiao, X., Ye, A., Zhu, Q., & Chen, C. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2301-4 · Cited by 20
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
“Beyond T2DM, insulin resistance is seen in most metabolic disorders, such as obesity, dyslipidemia, and metabolic syndrome (Samuel and Shulman, 2016).”
Glöde, A., Naumann, J., Gnad, T., Cannone, V., Kilić, A., Burnett, J. C. J., & Pfeifer, A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.010 · Cited by 22
“insulin receptor autophosphorylation or inhibition Akt/PKB with subsequent impaired signal propagation [41,76].”
BackgroundHashiguchi, A., Hitachi, K., Zhu, W., Tian, J., Tsuchida, K., & Komatsu, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.025 · Cited by 22
Loves, S., van Groningen, L., Filius, M., Mekking, M., Brandon, T., Tack, C. J., Hermus, A., & de Boer, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00161 · Cited by 21
Mariné-Casadó, R., Domenech-Coca, C., Bas-Prior, J. M. D., Bladé, C., Caimari, A., & Arola, L. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.013 · Cited by 24
Abulizi, A., Camporez, J. P., Zhang, D., Samuel, V. T., Shulman, G. I., & Vatner, D. F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.003 · Cited by 22
“Increases in hepatic Sn-1,2-DAG activate PKCε, which then impairs hepatocellular insulin signaling [22].”
BackgroundSelf-citationShitole, S. G., Biggs, M. L., Reiner, A. P., Mukamal, K. J., Djoussé, L., Ix, J. H., Barzilay, J. I., Tracy, R. P., Siscovick, D. S., & Kizer, J. R. (2019) · Diabetes Care · doi:10.2337/dc19-0723 · Cited by 23
“The resultant lipid excess promotes ectopic fat deposition, inflammation, and insulin resistance in liver and skeletal muscle, further impairing glucose disposal (31).”
BackgroundINPP4B protects from metabolic syndrome and associated disorders
Zhang, M., Ceyhan, Y., Kaftanovskaya, E. M., Vasquez, J. L., Vacher, J., Knop, F. K., Nathanson, L., Agoulnik, A. I., Ittmann, M., & Agoulnik, I. U. (2021) · Communications Biology · doi:10.1038/s42003-021-01940-6 · Cited by 22
Qiu, X., Han, Y. Y., Cao, C., Liao, Y., & Hu, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02768-8 · Cited by 22
“Similarly, LCI demonstrated stable predictive value, potentially due to its characteristic of comprehensively reflecting multiple lipid components [48].”
VLDL triglyceride accumulation in skeletal muscle and adipose tissue in type 2 diabetes
Søndergaard, E., & Nielsen, S. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000471 · Cited by 22
Pang, S., Miao, G., Zhou, Y., Du, Y., Rui, Z., & Zhao, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.957626 · Cited by 25
“Increased TG levels can increase free fatty acid (FFA) levels and promote FFA flux from adipose tissue to nonadipose tissue (20).”
BackgroundFerdowsi, P. V., Ahuja, K., Beckett, J. M., & Myers, S. (2023) · Molecules · doi:10.3390/molecules28062861 · Cited by 23
“…and high levels of reactive oxygen species (ROS), which negatively affect insulin secretion from pancreatic β cells and insulin sensitivity [62–65]. levels of reactive oxygen species (ROS), which negatively affect insulin secretion from pancreatic β cells and insulin sensitivity [62–65].”
Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
Shao, Y., Chen, S., Liu, H., & Liu, J. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00748-x · Cited by 21
“Insulin resistance impairs the inhibition of gluconeogenesis [48].”
BackgroundTetri, L. H., Diffee, G. M., Barton, G. P., Braun, R., Yoder, H. E., Haraldsdóttir, K., Eldridge, M. W., & Goss, K. N. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00326 · Cited by 20
“Skeletal muscle plays an important role in glucose disposition and defects in skeletal muscle function and insulin responsiveness are associated with an increased risk of metabolic disease (Samuel and Shulman, 2016).”
BackgroundConnolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 23
“In pathologic situations like obesity, regulation of insulin signaling is altered by numerous internal and external stimuli, including nutrients like lipids, leading to metabolic insulin resistance [13] and other consequences (discussed below).”
BackgroundThe tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner
Srikantan, S., Deng, Y., Cheng, Z.-M., Luo, A., Qin, Y., Gao, Q., Sande-Docor, G.-M., Tao, S., Zhang, X., Harper, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12661-0 · Cited by 19
Ramos-López, O., Riezu‐Boj, J. I., Milagro, F. I., Cuervo, M., Goñi, L., & Martínez, J. A. (2019) · Nutrients · doi:10.3390/nu12010033 · Cited by 20
“Insulin resistance (IR) is characterized by complete or partial insufficiency of insulin action on target tissues, being one of the first physiological abnormalities that precede the development of type 2 diabetes (T2D) and being usually related to concomitant metabolic chronic diseases such as obesity, non-alcoholic…”
BackgroundResultMatrix mechanics regulates muscle regeneration by modulating kinesin-1 activity
Chiang, W.-Y., Yu, H. W., Wu, M.-C., Huang, Y.-M., Chen, Y., Lin, J., Liu, Y.-W., You, L., Chiou, A., & Kuo, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122551 · Cited by 21
Zhang, J., Li, J., Zheng, Y., Zhu, C., Wu, Z., Wang, T., Li, Y., Zhu, J., Wei, S., Qian, H., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03769-1 · Cited by 31
“Hepatic uptake of these FFAs further augments triglyceride synthesis and gluco-neogenesis in the liver [141, 145].”
The SLC25A47 locus controls gluconeogenesis and energy expenditure
Yook, J.-S., Taxin, Z. H., Yuan, B., Oikawa, S., Auger, C., Mutlu, B., Puigserver, P., Hui, S. T., & Kajimura, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216810120 · Cited by 23
Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats
Gostelow, R., & Hazuchova, K. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.02.001 · Cited by 25
Guerrero‐Wyss, M., Yans, C., Boscan, A., Durán, P., Parra-Soto, S. L., & Angarita, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310779 · Cited by 19
“This results in increased blood glucose levels and compensatory hyperinsulinemia, which can further exacerbate insulin resistance and contribute to the development of metabolic syndrome [60].”
BackgroundHao, B., Lyu, L., Xu, J., Zhu, X., Cui, X., Gao, W., Qin, J., Huang, T., Ding, Y., Zhang, Z., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02132-2 · Cited by 23
“Patients with IR typically exhibit a heightened risk of metabolic disorders, such as hyperglycemia, dyslipidemia, and hypertension, all closely linked to negative CVD outcomes [35–37].”
BackgroundLiu, G., Li, M., Saeed, M., Xu, Y., Ren, Q., & Sun, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17465 · Cited by 19
Sabater, A. G., Ribot, J., Priego, T., Vazquez, I., Frank, S., Palou, A., & Buchwald‐Werner, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477606 · Cited by 21
Stalin, A., Kandhasamy, S., Kannan, B. S., Verma, R. S., Savarimuthu Ignacimuthu, S. J., Kim, Y., Shao, Q., Chen, Y., & Perumal, P. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103579 · Cited by 20
Katsnelson, G., & Ceddia, R. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00304.2020 · Cited by 20
Brown, A. L., & Brown, J. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.016 · Cited by 25
“17 where they normally act to negatively regulate insulin receptor-driven signaling events [86].”
Nowotny, B., KAHL, S., Klüppelholz, B., Hoffmann, B. H., Giani, G., Livingstone, R. S., Nowotny, P., Stamm, V., Herder, C., Tura, A., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.005 · Cited by 21
Sweatman, C. Z. W. H. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110037 · Cited by 22
Inaba, Y., Hashiuchi, E., Watanabe, H., Kimura, K., Sato, M., Kobayashi, M., Matsumoto, M., Kitamura, T., Kasuga, M., & Inoue, H. (2019) · Endocrinology · doi:10.1210/en.2019-00422 · Cited by 18
Type 3 Diabetes: Linking Insulin Resistance to Cognitive Decline
Chapple, B. E., Bayliss, E., Woodfin, S., Smith, M., Winter, J., & Moore, W. (2025) · Diseases · doi:10.3390/diseases13110359 · Cited by 25
“Parallel lipotoxic signals from diacylglycerols activate conventional/novel PKC isoforms (e.g., PKC ε / θ ), leading to IRS-1 serine phosphorylation, impaired PI3K/Akt transduction, and neuronal insulin resistance that further removes tonic restraint on GSK-3 β [108,109].”
Greabu, M., Bădoiu, S. C., Stănescu-Spînu, I.-I., Miricescu, D., Totan, A., Badoiu, S. E., Costagliola, M., & Jinga, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189782 · Cited by 21
“hepatocytes, adipocytes, and myocytes [101].”
BackgroundInfluentialObesity, Body Image Dissatisfaction, and Sexual Dysfunction: A Narrative Review
McNabney, S. M. (2022) · Sexes · doi:10.3390/sexes3010002 · Cited by 28
Kang, S., Lee, A. G., Im, S., Oh, S. J., Yoon, H. J., Park, J. H., & Pak, Y. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314871 · Cited by 19
“In the lean state, insulin inhibits lipolysis and promotes glucose uptake in the essential insulin-sensitive tissues, skeletal muscle, liver, and adipose tissue [52].”
BackgroundAttanzio, A., Restivo, I., Tutone, M., Tesoriere, L., Allegra, M., & Livrea, M. A. (2022) · Antioxidants · doi:10.3390/antiox11122364 · Cited by 22
Xu, M. J., Xue, H., Kong, L., Lin, L., & Zheng, G. (2023) · Plant Foods for Human Nutrition · doi:10.1007/s11130-023-01052-y · Cited by 21
Wei, Y., Liu, W., & Liu, J. (2023) · Environment International · doi:10.1016/j.envint.2023.108090 · Cited by 18
Huang, X., Han, J., Nong, Y., Sun, J., Wang, Q., Zhai, Z., Mo, J., Huang, J., & Lu, W. (2023) · International Wound Journal · doi:10.1111/iwj.14344 · Cited by 20
“14 Therefore, functional IR evaluation aids in the identification of diabetic patients at high risk for developing severe complications.”
BackgroundSong, Z., An, Y., Li, Z., Shang, Y., Chen, R., Yang, Z., Guo, Z., Zhang, Y., Wen, T., Ogaji, O. D., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155957 · Cited by 18
Dapagliflozin restores insulin and growth hormone secretion in obese mice
Huang, Z., Huang, L., Wang, C., Zhu, S., Qi, X., Chen, Y., Zhang, Y., Cowley, M. A., Veldhuis, J. D., & Chen, C. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0385 · Cited by 18
“2015, Samuel & Shulman 2016, Morita et al.”
BackgroundBarazzoni, R., Cappellari, G. G., Zanetti, M., Klaus, K. A., Semolic, A., Johnson, M. L., & Nair, K. S. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.014 · Cited by 20
“Excess nutrient intake and impaired nutrient utilization may contribute to the onset of obesity-associated insulin resistance, and related low-grade systemic inflammation is reported to play a relevant pathogenic role (5, 7, 8).”
BackgroundRenton, M. C., McGee, S. L., & Howlett, K. F. (2020) · Obesity Reviews · doi:10.1111/obr.13145 · Cited by 18
Singh, M., Adame, O. B., Nickas, M., Robison, J., Khatchadourian, C., & Venketaraman, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833355 · Cited by 20
Epigenetic markers to further understand insulin resistance
Ling, C., & Rönn, T. (2016) · Diabetologia · doi:10.1007/s00125-016-4109-y · Cited by 21
Rigal, S., Casas, B., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Müllers, E., Karlsson, F. H., Clausen, M., Hansson, S., Leonard, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06514-w · Cited by 24
“Glucocorticoids increase hepatic glucose productionviagluconeogenesis 43 andpromotehepaticlipidaccumulation 26 , suspected to induce insulin resistance 44 .”
Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications
Crintea, I. N., Cîndrea, A. C., Mederle, O. A., Trebuian, C. I., & Timar, R. Z. (2025) · Diseases · doi:10.3390/diseases13030069 · Cited by 31
“This dysfunction contributes to a predisposition to hyperkalemia, which can disrupt cardiac electrophysiology and lead to arrhythmias [71].”
Cheng, F., Yuan, G., He, J., Shao, Y., Zhang, J., & Guo, X. (2020) · Diagnostic Pathology · doi:10.1186/s13000-019-0914-1 · Cited by 16
Zhou, Y., Tao, H., Xu, N., Zhou, S., Peng, Y., Zhu, J., Liu, S., & Chang, Y. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14379 · Cited by 18
Xing, W., Wang, L., Gu, W., Liang, M., Wang, Z., Fan, D., & Zhang, B. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-24177-0 · Cited by 18
“Hyperphosphorylation of tyrosine or threonine residue of insulin receptor [Samuel and Shulman 2016], provoked oxidative injury and inflammation [Skytte et al.”
BackgroundGlucagon changes substrate preference in gluconeogenesis
Xu, H., Wang, Y., Kwon, H., Shah, A. M., Kalemba, K. M., Su, X., He, L., & Wondisford, F. E. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102708 · Cited by 18
“While defects in insulin signaling are central to diabetes pathogenesis, the effect of insulin signaling on GNG appears to be largely indirect through substrate availability (6 – 9).”
MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes
Dou, L., Wang, S., Huang, X., Sun, X., Zhang, Y., Shen, T., Guo, J., Man, Y., Tang, W., & Li, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8312 · Cited by 17
Garg, P. K., Biggs, M. L., Kaplan, R. C., Kizer, J. R., Heckbert, S. R., & Mukamal, K. J. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.016 · Cited by 18
Somvanshi, P. R., Tomar, M., & Kareenhalli, V. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-50889-4 · Cited by 18
“3(iv)) shows that insulin signalling is inhibited by higher FA levels (via PKC activation) 49 even at high glucose levels.”
BackgroundDirect and indirect modulation of LPS-induced cytokine production by insulin in human macrophages
Klauder, J., Henkel, J., Vahrenbrink, M., Wohlenberg, A.-S., Camargo, R. G., & Püschel, G. P. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155241 · Cited by 17
Joseph, A., Parvathy, S., & Varma, K. K. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5123241 · Cited by 17
Costa, J. S. R., Fonseca, G. F. A. C., Ottone, N. C. D. S., Silva, P. A., Antonaccio, R. F., Silva, G., Rocha, M. D. S. A., Coimbra, C. C., Esteves, E. A., Mang, Z. A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119639 · Cited by 21
Bao, S., Wang, X., Cho, S. B., Wu, Y., Wei, C., Han, S., Bao, L., Wu, Q., Ao, W., & Nan, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656220 · Cited by 19
Undertreatment or Overtreatment With Statins: Where Are We?
García-Fernández-Bravo, I., Torres-Do-Rego, A., López-Farré, A. J., Valle, F. G., Rodríguez, P. D., & Alvarez-Sala-Walther, L. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.808712 · Cited by 23
Sarcopenic obesity in liver disease: Handling both sides of the penny
Hui, Y., Cui, B., Wang, X., Sun, M., Li, Y., Yang, W., Guo, G., Mao, L., Yu, Z., Fan, X., et al. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.10 · Cited by 19
“87 The consequence of insulin resistance in skeletal muscle is muscle loss, and a dysregulated insulin signaling pathway leads to an imbalance between protein synthesis and proteolysis through mammalian target of rapamycin (mTOR) inactivation and enhanced transcription of E3 ubiquitin ligases.”
The role of pancreas to improve hyperglycemia in STZ-induced diabetic rats by thiamine disulfide
Rad, M. G., Sharifi, M., Meamar, R., & Soltani, N. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00211-5 · Cited by 21
“If insulin resistance develops, the effectiveness of insulin decreases; [6, 7] insulin resistance (IR) is a dynamic pathological disorder resulting from inadequate cellular response to insulin [8, 9] in insulindependent cells, which occurs in various metabolic disorders, including type 2 diabetes (T2D) and metabolic s…”
BackgroundWei, A., Liu, J., Wang, L., Zheng, S., & Cong, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065780 · Cited by 17
Zhang, X., Saarinen, A. M., Campbell, L. E., Filippis, E. A. D., & Liu, J. (2017) · Diabetes · doi:10.2337/db17-0862 · Cited by 19
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
Mishina, E. Е., Mayorov, A. Y., Bogomolov, P., Matsievich, M. V., Kokina, K. Y., & Васильевна, Б. А. (2017) · Diabetes Mellitus · doi:10.14341/dm9372 · Cited by 22
Shen, Y., Yang, S., Hu, X., Zhang, M., Ma, X., Wang, Z., Hou, Y., & Bai, G. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.02.035 · Cited by 16
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 30
“Women with obesity and PCOS, in particular, exhibit hepatic insulin resistance, which impairs glycogen synthesis while promoting gluconeogenesis, resulting in hyperglycemia [52].”
Moriyama, K. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.108380 · Cited by 31
“Targeted interventions, including lifestyle modifications, pharmacological agents, and emerging metabolic therapies, hold promise in mitigating the adverse effects of IR and reducing the global burden of metabolic diseases[31,32].”
Loves, S., van Groningen, L. F. J., Filius, M., Mekking, M., Brandon, T., Tack, C. J., Hermus, A. R., & de Boer, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01147 · Cited by 16
Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle
Vandanmagsar, B., Yu, Y., Simmler, C., Dang, T. N., Kuhn, P. E., Poulev, A., Ribnicky, D., Pauli, G. F., & Floyd, Z. E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112188 · Cited by 17
Kakehi, S., Tamura, Y., Ikeda, S., Kaga, N., Taka, H., Ueno, N., Shiuchi, T., Kubota, A., Sakuraba, K., Kawamori, R., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00254.2020 · Cited by 21
Heras, N. D. L., & Lahera, V. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02638-8 · Cited by 20
“Obesity and T2D can induce cardiomyocytes hypertrophy through overactivity of growth pathway [23].”
BackgroundInfluentialStem Cell-Derived Islets for Type 2 Diabetes
Salib, A., Cayabyab, F., & Yoshihara, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095099 · Cited by 16
Serrano, A., Palou, A., Bonet, M. L., & Ribot, J. (2022) · Nutrients · doi:10.3390/nu14112259 · Cited by 19
“From the muscle results, protection against HFD-induced insulin resistance/prediabetes can be anticipated in the mice neonatally treated with NR, considering the close relationship between muscle (intramyocellular) lipid content and systemic insulin resistance, and that muscle lipids primarily reflect muscle triacylgl…”
BackgroundWu, Z., Xiao, Y., Zhou, F., Chen, J., Chen, X., Hou, A., Wang, Y., & Li, Z. (2022) · Molecules · doi:10.3390/molecules27196159 · Cited by 18
Pan, L., Gao, Y., Han, J., Li, L., Wang, M., Peng, H., Liao, J., Wan, H., Xiang, G., & Han, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1046223 · Cited by 17
Kim, H., Lee, K., Kim, J., Shim, J.-J., Lim, J., Kim, J.-Y., & Lee, J.-L. (2023) · Microorganisms · doi:10.3390/microorganisms11102466 · Cited by 17
“However, if hyperinsulinemia and hyperglycemia persist, fatty acid oxidation is suppressed and triglyceride synthesis is promoted [14,15].”
BackgroundDeng, C., Ou, Q., Ou, X., & Pan, D. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078933 · Cited by 21
Mitochondria and endoplasmic reticulum: Targets for a better insulin sensitivity in skeletal muscle?
Boulinguiez, A., Staels, B., Duez, H., & Lancel, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.011 · Cited by 28
“These events lead to the impairment of IR-IRS-PI3K-Akt signaling and to a reduction in glucose uptake (For review: [1]).”
BackgroundInfluentialWu, J., Tao, W., Bu, D., Zhao, Y., Zhang, T., Chong, D., Xue, B., Xing, Z., & Li, C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13537 · Cited by 15
Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
Hodson, L., & Karpe, F. (2019) · Endocrine Connections · doi:10.1530/ec-19-0350 · Cited by 18
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.